Biopharma/Biotech Analyst Chen and Biotech Analysts Schmidt, Schimmer & Watsek, along with Dr. Sabari of NYU Langone Health System discuss which antibody drug conjugates are changing the treatment paradigm in oncology (relevant companies: PFE SGEN AMAM MRK JNJ LLY IMGN BCYC VINC MRSN ZYME) on an Analyst/Industry conference call to be held on November 17 at 11 am. Webcast Link
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PFE:
- Serina Therapeutics announces POZ polymer license agreement with Pfizer
- Astellas Pharma, Pfizer announce FDA approval of Xtandi sNDA
- Cantor biotech/biopharma analysts hold analyst/industry conference call
- Pfizer (NYSE:PFE) to Layoff 500 Workers at UK Site
- Pfizer to cut 500 jobs, discontinue PSSM operations in Kent, Sky News reports